06160 Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

0 Analyst Rating

Wall Street analysts forecast 06160 stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for 06160 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

0 Hold

0 Sell

Current: 0.000

Low

Averages

High

Current: 0.000

Low

Averages

High

CCBI

upgrade

$230 -> $234

2025-11-10

Reason

CCBI

Price Target

$230 -> $234

2025-11-10

upgrade

Reason

The analyst rating for BEONE MEDICINES is "Outperform" based on several key factors highlighted in the article. The company turned around from a significant loss in the previous quarter to a net profit that exceeded market expectations, reporting a profit of $125 million in 3Q25 compared to the consensus estimate of $80 million. Additionally, total product revenue for the quarter increased by 40% year-over-year, aligning with the broker's forecasts. CCBI also raised its target price for the stock, reflecting a positive outlook based on a sum-of-the-parts valuation method and discounted cash flow analysis, which suggests that the stock is undervalued compared to its peers in the biotech sector.

Valuation Metrics

The current forward P/E ratio for BEIGENE (06160.HK) is 48.54, compared to its 5-year average forward P/E of 1.63. For a more detailed relative valuation and DCF analysis to assess BEIGENE 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

1.63

Current PE

48.54

Overvalued PE

68.98

Undervalued PE

-65.72

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-8.29

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

19.97

Undervalued EV/EBITDA

-36.54

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

12.10

Current PS

0.00

Overvalued PS

21.10

Undervalued PS

3.10

Financials

Annual

Quarterly

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

06160 News & Events

Events Timeline

No data

News

9.0

01-06Businesswire

BeOne Reports ZIIHERA Trial Results, Significant Survival Improvement Observed

1.0

2025-12-23Yahoo Finance

BeOne Medicines to Present at 2026 J.P. Morgan Healthcare Conference

9.0

2025-12-08aastocks

China's NRDL Set to Launch Next Year; BEONE MEDICINES Secures Two Drugs on Shortlist

People Also Watch

Frequently Asked Questions

What is BEIGENE (06160) stock price today?

The current price of 06160 is 198.8 USD — it has increased 3.38 % in the last trading day.

What is BEIGENE (06160)'s business?

What is the price predicton of 06160 Stock?

Wall Street analysts forecast 06160 stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for 06160 is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is BEIGENE (06160)'s revenue for the last quarter?

BEIGENE revenue for the last quarter amounts to NaN USD, decreased % YoY.

What is BEIGENE (06160)'s earnings per share (EPS) for the last quarter?

BEIGENE. EPS for the last quarter amounts to USD, decreased % YoY.

What changes have occurred in the market's expectations for BEIGENE (06160)'s fundamentals?

The market is revising No Change the revenue expectations for 06160 for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by %.

How many employees does BEIGENE (06160). have?

BEIGENE (06160) has 0 emplpoyees as of January 07 2026.

What is BEIGENE (06160) market cap?

Today 06160 has the market capitalization of 0.00 USD.

06160

Overview

Forecast

Valuation

Earnings

06160

Overview

Forecast

Valuation

Earnings

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

06160 News & Events

Events Timeline

No data

News

People Also Watch

Frequently Asked Questions

What is BEIGENE (06160) stock price today?

What is BEIGENE (06160)'s business?

What is the price predicton of 06160 Stock?

What is BEIGENE (06160)'s revenue for the last quarter?

What is BEIGENE (06160)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for BEIGENE (06160)'s fundamentals?

How many employees does BEIGENE (06160). have?

What is BEIGENE (06160) market cap?